Chiara Benedetto is Full Professor, Chair of Obstetrics and Gynecology 1 – Sant’Anna University Hospital – and Director of the School of Specialization of the University of Torino, Italy.

She is Chair of the Committee for Women’s Health and Human Rights of the International Federation of Gynaecology and Obstetrics (FIGO), Past Chair of the Surgical Group of the Union Europèen des Medecins Specialistes (UEMS) and Past President of the European Board and College of Obstetrics and Gynecology (EBCOG).

During her tenure as President of EBCOG, she worked on and launched at the European Parliament the two documents “Standards of Care for Women’s Health in Europe” aimed at promoting and improving the quality of OBGYN care across Europe. She also begun the EBCOG Simulation Consortium of Hospitals and Institutions, aimed at validating simulators in training programmes and at promoting and assisting in the broad implementation of simulation-based training in the field of OBGYN in all European countries.

She has published more than 600 scientific papers, including about 300 in peer review journals, three monographs, two OBGYN textbooks, more than 90 book chapters.

Her dedication to Women’s Health has led her, and other professional women, to set-up a non-profit organisation called “Medicine Tailored to the Woman” whose goals are those of improving women’s safety and wellbeing in places of care and cure.

Link to Abstract of the presentation


Dr. Rigmor Berg has a PhD in Health Promotion and Behaviour from the University of Georgia (USA). Her professional interests and areas of expertise are Evidence-Based Practice, HIV prevention, and other sexual health and equity issues. She is Department Director at the Norwegian Institute of Public Health, and Professor at the University of Tromsø.

Link to Abstract of the presentation


Søren Brostrøm worked as a subspecialised urogynaecologist and associate professor at Herlev University Hospital until 2011. He holds a PhD from the University of Copenhagen, with research in the neurophysiology of pelvic floor function in women. He also has Master of Public Administration. He joined the Danish Health Authority in 2011 as Director of Hospital Planning. Since 2015 he has been the Director General of the Danish Health Authority.

Link to Abstract  of the presentation



Christina Damsted Petersen, has since 2015 run a private clinic in central Copenhagen offering treatment in the field of gynecology and Female Sexual Health problems.
From 2013 to 2015 she was head of the vulva team at department of Gynecology and Obstetrics in Herlev, Copenhagen.
Received her Ph.d in 2009 with the ph.d. title: What predicts diagnosis, pain relief and sexuality in women with vulvodynia? Botox – a new treatment for vulvodynia?
She is particularly interested in vulvar diseases, vulvodynia, chronic gynecological and sexual pain, general gynecology and urogynecology.
Co – founder and past president of the Danish society for studies in vulvar diseases, DSVL. Fellow of the International Society for the Study on Vulvar Diseases, ISSVD since 2007.
Many years experience from working in the field of Sexual Medicine following 5 years of employment at the Sexological Clinic in Copenhagen. Is certified as Counsellor in Sexual Medicine.
Previous board member of the Scandiavian Society for Sexual Medicine (SSSM), and former long term member of the educational committee under the European Society for Sexual Medicine (ESSM).
Has written several papers on chronic sexual pain and vulvodynia and contributed with several chapters to the first ESSM Syllabus of Sexual medicine and to the upcoming Danish book on Sexual Medicine.

Link to Abstract of the presentation


Bo Jacobsson, Professor and member of the Board of Directors at Sahlgrenska Academy, Department of Obstetrics and Gynecology, University of Gothenburg, Gothenburg, Sweden. Head of Perinatal Research Laboratory at Sahlgrenska University Hospital, Gothenburg, Sweden and Senior researcher at Institute of Public Health, Oslo, Norway. Clinical scientist with speciality in Obstetrics and Maternal/Fetal Medicine. Leading expert on mechanisms and epidemiology of preterm delivery. Prof. Jacobsson has published more than 200 per reviewed papers between 2002-2017. Among other journals he has published in Nature, Science, New Englands Journal of Medicine, Nature Genetics, PLOS Medicine and JAMA. He has been invited to lecture to more than 100 international scientific conferences.

Link to Abstract of the presentation


Ann Thurin Kjellberg is senior consultant and associated professor at Reproductive medicine, Sahlgrenska University Hospital in Göteborg, Sweden where she has worked since 1997. Her thesis in 2005 was called Elective single embryo transfer. From 2003 she is in charge of the oocyte donation program and for the last ten years also for pre-implantation genetic diagnosis (PGD) and fertility preservation at the unit. She recently published a Nordic randomized controlled trial with participation from Sweden, Denmark and Iceland showing the results of weight reduction intervention for obese infertile women prior to IVF.

Link to Abstract of the presentation


Annemette W. Lykkebo

Senior consultant in Obstetrics and Gynecology since 2009.
Currently Head of Department of Gyn. Obs. at Kolding Hospital.
Special interests in vulva diseases and co-founder of the vulva clinic in 2009 (1200 annual visits).
Main research areas have been in the field of incontinence, vulva and especially body perception.
Many lectures and trainings sessions in vulva diseases, vulva-perception and -resection.

Link to Abstract of the presentation


David McIntyre, Professor, MB BS and MD (Qld) FRACP, Head of Mater Clinical Unit, University of Queensland.
Director of Obstetric Medicine. Mater Health Services. Brisbane, Australia

Professor David McIntyre trained in Endocrinology in Australia and Belgium. .  He is Director of Obstetric Medicine at Mater Health Services and Head of the Mater Clinical Unit at the University of Queensland.
David has published over 160 papers (>8300 citations), primarily in the field of medical complications of pregnancy with a focus on diabetes and obesity. His main interest are around the effects of diabetes, obesity and high blood pressure during pregnancy on the health of Mothers and Babies, both during pregnancy and with long term follow up.
In 2016, he became the first Australian trained clinician to receive the Norbert Freinkel Award for contributions to diabetes in pregnancy from the American Diabetes Association.  In 2017 he was awarded a Visiting Professor Fellowship from the Danish Diabetes Academy in collaboration with clinical researchers in Copenhagen, Odense and Aarhus.

Link to Abstract of the presentation


Anja Pinborg is a medical expert in reproductive medicine and professor in Obs/gyne at Rigshospitalet, University of Copenhagen, Denmark.
She graduated medical school at University of Copenhagen in 1996 and became specialist in obstetrics and gynecology in 2010. She has since then worked as an expert in reproductive medicine at the Fertility Clinics at Rigshospitalet and as professor at Hvidove Hospital from 2013 to 2017. She defended her doctoral thesis entitled “Twin pregnancies – Risks and prevention” in 2006. Anja Pinborg has worked scientifically with reproductive medicine since 2000 and has published 121 scientific papers in peer-reviewed journals and authored seven book-chapters. Her h-index is 34. She has been invited speaker at numerous international congresses.

Anja Pinborg was president for the Nordic Fertility Society (2011-2015) and is member of the board of the Committee of Nordic ART and Safety (CoNARTaS). She has been associate editor for Human Reproduction Update (2009-2013) and for Acta Obs/Gyn Scand (2013-2015). She is current editor in chief for Danish Medical Journal (DMJ) and section editor for Reproductive Biomedicine Online. She has been assessor of national and international PhD dissertations. She has received more scientific prizes including the NFOG prize for younger researchers and the ESHRE prize for experienced clinical research. She is current member of the ESHRE EXCO.

Her main research areas are reproductive epidemiology including safety and quality aspects of ART with focus on ART children and clinical trials on optimizing ART reducing the risk of OHSS and multiple pregnancies.

Link to Abstract of the presentation


Anne Cathrine (Annetine) Staff ( and
Home page:

Dr. Staff, MD, PhD, is a specialist in Gynecology and Obstetrics. She currently works as full-time Professor at the Faculty of Medicine, University of Oslo and is Head of Research at the Oslo University Hospital, Division of Obstetrics and Gynaecology. She continues part-time work as a clinical consultant. The main research area is within molecular understanding of pregnancy complications, including preeclampsia, and future maternal cardiovascular health.

Dr. Staff was the EPG (European Placenta Group) Spokesperson 2011-17 and the Vice-President of the ISSHP (International Society for the Study of Hypertension in Pregnancy) 2012-16, and is currently ISSHP Executive Committee member.

Link to Abstract of the presentation


Basky Thilaganathan, Professor and Director of Fetal Medicine, Institution: St George’s University Hospitals NHS Foundation Trust, London
Tel: +44 (0)20 8725 0071 – E-mail: – Websites:

Basky Thilaganathan undertook his undergraduate training at King’s College London, where he obtained a BSc in Genetic Engineering (1995) and MBBS (1988). He was appointed Consultant and Director of Fetal Medicine at St George’s, University of London in 1999. He has been awarded the Fellowship of the Royal College of Obstetricians and Gynaecologists (RCOG, 2006), an Honorary Doctorate (PhD) from Uppsala University (2007) and made Professor, University of London in 2008. His research interests are in maternal cardiac function, placental function, fetal growth and preeclampsia (TED talk:

He is the lead trainer for the Maternal-Fetal medicine sub-speciality training programme at St George’s Hospital and Editor-in Chief of Ultrasound in Obstetrics and Gynaecology. He is a Council Member on the RCOG and the UK National Screening Committee. He is also the Clinical Lead for the first dedicated high-throughput NIPT lab in the UK NHS (

Link to Abstract of the presentation